Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients

Rationale Hereditary angioedema (HAE) attacks result from uncontrolled contact system activation which generates a burst of plasma kallikrein (pKal) that cleaves high-molecular-weight kininogen (HMWK) to produce 2-chain HMWK and the edema-inducing peptide, bradykinin.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB252-AB252
Hauptverfasser: Davis-Lorton, Mark A., MD FAAAAI, Busse, Paula J., MD FAAAAI, Banerji, Aleena, MD, Shennak, Mustafa, Lumry, William R., MD FAAAAI, Wedner, H. James, MD FAAAAI, Jacobs, Joshua S., MD, Baker, James W., MD FAAAAI, Bernstein, Jonathan A., MD, Lockey, Richard F., MD, Li, H. Henry, MD PhD, Craig, Timothy J, Cicardi, Marco, Riedl, Marc A., MD MS, Al-Ghazawi, Ahmad, Soo, Carolyn, Iarrobino, Ryan, Sexton, Daniel, TenHoor, Christopher, Faucette, Ryan, Biedenkapp, Joseph C, Chyung, Yung H, Adelman, Burt
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page AB252
container_issue 2
container_start_page AB252
container_title Journal of allergy and clinical immunology
container_volume 137
creator Davis-Lorton, Mark A., MD FAAAAI
Busse, Paula J., MD FAAAAI
Banerji, Aleena, MD
Shennak, Mustafa
Lumry, William R., MD FAAAAI
Wedner, H. James, MD FAAAAI
Jacobs, Joshua S., MD
Baker, James W., MD FAAAAI
Bernstein, Jonathan A., MD
Lockey, Richard F., MD
Li, H. Henry, MD PhD
Craig, Timothy J
Cicardi, Marco
Riedl, Marc A., MD MS
Al-Ghazawi, Ahmad
Soo, Carolyn
Iarrobino, Ryan
Sexton, Daniel
TenHoor, Christopher
Faucette, Ryan
Biedenkapp, Joseph C
Chyung, Yung H
Adelman, Burt
description Rationale Hereditary angioedema (HAE) attacks result from uncontrolled contact system activation which generates a burst of plasma kallikrein (pKal) that cleaves high-molecular-weight kininogen (HMWK) to produce 2-chain HMWK and the edema-inducing peptide, bradykinin.
doi_str_mv 10.1016/j.jaci.2015.12.908
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1765336112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674915026500</els_id><sourcerecordid>3953756691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2728-74a5d5f72919cedf3ecec25495efb72318245a33c93f31382cc5c7210bbc35523</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpodukf6AnQ892NKOVbUEohDRpQgJZaAu5Ce141Mjx2qnkFPbfV2YLhRwCA2LgPenpe0J8AlmBhPqkr3pHoUIJugKsjGzfiBVI05R1i_qtWElpoKybtXkvPqTUy7yr1qzE_ebBxZ2jqduPbheouPCeaS4mX3y9L9EoWUxjsRlc2rnixg1DeIwcxiLPFUfuwuzivjgbf4WJO86ajZsDj3M6Fu-8GxJ__HceiZ-XFz_Or8rbu2_X52e3JWGDbdmsne60b9CAIe68YmJCvTaa_bZBBS2utVOKjPIKVItEmhoEud2S0hrVkfh8uPcpTr-fOc22n57jmJ-00NRaqRpgUeFBRXFKKbK3TzHscnQL0i4EbW8XgnYhaAFtJphNpwcT5_x_AkebKP8txwwxM7LdFF63f3lhpyGMgdzwyHtO_2PahFba70tFS0OgJdZaSvUXVR2MuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765336112</pqid></control><display><type>article</type><title>Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Davis-Lorton, Mark A., MD FAAAAI ; Busse, Paula J., MD FAAAAI ; Banerji, Aleena, MD ; Shennak, Mustafa ; Lumry, William R., MD FAAAAI ; Wedner, H. James, MD FAAAAI ; Jacobs, Joshua S., MD ; Baker, James W., MD FAAAAI ; Bernstein, Jonathan A., MD ; Lockey, Richard F., MD ; Li, H. Henry, MD PhD ; Craig, Timothy J ; Cicardi, Marco ; Riedl, Marc A., MD MS ; Al-Ghazawi, Ahmad ; Soo, Carolyn ; Iarrobino, Ryan ; Sexton, Daniel ; TenHoor, Christopher ; Faucette, Ryan ; Biedenkapp, Joseph C ; Chyung, Yung H ; Adelman, Burt</creator><creatorcontrib>Davis-Lorton, Mark A., MD FAAAAI ; Busse, Paula J., MD FAAAAI ; Banerji, Aleena, MD ; Shennak, Mustafa ; Lumry, William R., MD FAAAAI ; Wedner, H. James, MD FAAAAI ; Jacobs, Joshua S., MD ; Baker, James W., MD FAAAAI ; Bernstein, Jonathan A., MD ; Lockey, Richard F., MD ; Li, H. Henry, MD PhD ; Craig, Timothy J ; Cicardi, Marco ; Riedl, Marc A., MD MS ; Al-Ghazawi, Ahmad ; Soo, Carolyn ; Iarrobino, Ryan ; Sexton, Daniel ; TenHoor, Christopher ; Faucette, Ryan ; Biedenkapp, Joseph C ; Chyung, Yung H ; Adelman, Burt</creatorcontrib><description>Rationale Hereditary angioedema (HAE) attacks result from uncontrolled contact system activation which generates a burst of plasma kallikrein (pKal) that cleaves high-molecular-weight kininogen (HMWK) to produce 2-chain HMWK and the edema-inducing peptide, bradykinin.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2015.12.908</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Allergy and Immunology ; Drug dosages ; Plasma</subject><ispartof>Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB252-AB252</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Feb 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2728-74a5d5f72919cedf3ecec25495efb72318245a33c93f31382cc5c7210bbc35523</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674915026500$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Davis-Lorton, Mark A., MD FAAAAI</creatorcontrib><creatorcontrib>Busse, Paula J., MD FAAAAI</creatorcontrib><creatorcontrib>Banerji, Aleena, MD</creatorcontrib><creatorcontrib>Shennak, Mustafa</creatorcontrib><creatorcontrib>Lumry, William R., MD FAAAAI</creatorcontrib><creatorcontrib>Wedner, H. James, MD FAAAAI</creatorcontrib><creatorcontrib>Jacobs, Joshua S., MD</creatorcontrib><creatorcontrib>Baker, James W., MD FAAAAI</creatorcontrib><creatorcontrib>Bernstein, Jonathan A., MD</creatorcontrib><creatorcontrib>Lockey, Richard F., MD</creatorcontrib><creatorcontrib>Li, H. Henry, MD PhD</creatorcontrib><creatorcontrib>Craig, Timothy J</creatorcontrib><creatorcontrib>Cicardi, Marco</creatorcontrib><creatorcontrib>Riedl, Marc A., MD MS</creatorcontrib><creatorcontrib>Al-Ghazawi, Ahmad</creatorcontrib><creatorcontrib>Soo, Carolyn</creatorcontrib><creatorcontrib>Iarrobino, Ryan</creatorcontrib><creatorcontrib>Sexton, Daniel</creatorcontrib><creatorcontrib>TenHoor, Christopher</creatorcontrib><creatorcontrib>Faucette, Ryan</creatorcontrib><creatorcontrib>Biedenkapp, Joseph C</creatorcontrib><creatorcontrib>Chyung, Yung H</creatorcontrib><creatorcontrib>Adelman, Burt</creatorcontrib><title>Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients</title><title>Journal of allergy and clinical immunology</title><description>Rationale Hereditary angioedema (HAE) attacks result from uncontrolled contact system activation which generates a burst of plasma kallikrein (pKal) that cleaves high-molecular-weight kininogen (HMWK) to produce 2-chain HMWK and the edema-inducing peptide, bradykinin.</description><subject>Allergy and Immunology</subject><subject>Drug dosages</subject><subject>Plasma</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVpodukf6AnQ892NKOVbUEohDRpQgJZaAu5Ce141Mjx2qnkFPbfV2YLhRwCA2LgPenpe0J8AlmBhPqkr3pHoUIJugKsjGzfiBVI05R1i_qtWElpoKybtXkvPqTUy7yr1qzE_ebBxZ2jqduPbheouPCeaS4mX3y9L9EoWUxjsRlc2rnixg1DeIwcxiLPFUfuwuzivjgbf4WJO86ajZsDj3M6Fu-8GxJ__HceiZ-XFz_Or8rbu2_X52e3JWGDbdmsne60b9CAIe68YmJCvTaa_bZBBS2utVOKjPIKVItEmhoEud2S0hrVkfh8uPcpTr-fOc22n57jmJ-00NRaqRpgUeFBRXFKKbK3TzHscnQL0i4EbW8XgnYhaAFtJphNpwcT5_x_AkebKP8txwwxM7LdFF63f3lhpyGMgdzwyHtO_2PahFba70tFS0OgJdZaSvUXVR2MuQ</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Davis-Lorton, Mark A., MD FAAAAI</creator><creator>Busse, Paula J., MD FAAAAI</creator><creator>Banerji, Aleena, MD</creator><creator>Shennak, Mustafa</creator><creator>Lumry, William R., MD FAAAAI</creator><creator>Wedner, H. James, MD FAAAAI</creator><creator>Jacobs, Joshua S., MD</creator><creator>Baker, James W., MD FAAAAI</creator><creator>Bernstein, Jonathan A., MD</creator><creator>Lockey, Richard F., MD</creator><creator>Li, H. Henry, MD PhD</creator><creator>Craig, Timothy J</creator><creator>Cicardi, Marco</creator><creator>Riedl, Marc A., MD MS</creator><creator>Al-Ghazawi, Ahmad</creator><creator>Soo, Carolyn</creator><creator>Iarrobino, Ryan</creator><creator>Sexton, Daniel</creator><creator>TenHoor, Christopher</creator><creator>Faucette, Ryan</creator><creator>Biedenkapp, Joseph C</creator><creator>Chyung, Yung H</creator><creator>Adelman, Burt</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20160201</creationdate><title>Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients</title><author>Davis-Lorton, Mark A., MD FAAAAI ; Busse, Paula J., MD FAAAAI ; Banerji, Aleena, MD ; Shennak, Mustafa ; Lumry, William R., MD FAAAAI ; Wedner, H. James, MD FAAAAI ; Jacobs, Joshua S., MD ; Baker, James W., MD FAAAAI ; Bernstein, Jonathan A., MD ; Lockey, Richard F., MD ; Li, H. Henry, MD PhD ; Craig, Timothy J ; Cicardi, Marco ; Riedl, Marc A., MD MS ; Al-Ghazawi, Ahmad ; Soo, Carolyn ; Iarrobino, Ryan ; Sexton, Daniel ; TenHoor, Christopher ; Faucette, Ryan ; Biedenkapp, Joseph C ; Chyung, Yung H ; Adelman, Burt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2728-74a5d5f72919cedf3ecec25495efb72318245a33c93f31382cc5c7210bbc35523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Allergy and Immunology</topic><topic>Drug dosages</topic><topic>Plasma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis-Lorton, Mark A., MD FAAAAI</creatorcontrib><creatorcontrib>Busse, Paula J., MD FAAAAI</creatorcontrib><creatorcontrib>Banerji, Aleena, MD</creatorcontrib><creatorcontrib>Shennak, Mustafa</creatorcontrib><creatorcontrib>Lumry, William R., MD FAAAAI</creatorcontrib><creatorcontrib>Wedner, H. James, MD FAAAAI</creatorcontrib><creatorcontrib>Jacobs, Joshua S., MD</creatorcontrib><creatorcontrib>Baker, James W., MD FAAAAI</creatorcontrib><creatorcontrib>Bernstein, Jonathan A., MD</creatorcontrib><creatorcontrib>Lockey, Richard F., MD</creatorcontrib><creatorcontrib>Li, H. Henry, MD PhD</creatorcontrib><creatorcontrib>Craig, Timothy J</creatorcontrib><creatorcontrib>Cicardi, Marco</creatorcontrib><creatorcontrib>Riedl, Marc A., MD MS</creatorcontrib><creatorcontrib>Al-Ghazawi, Ahmad</creatorcontrib><creatorcontrib>Soo, Carolyn</creatorcontrib><creatorcontrib>Iarrobino, Ryan</creatorcontrib><creatorcontrib>Sexton, Daniel</creatorcontrib><creatorcontrib>TenHoor, Christopher</creatorcontrib><creatorcontrib>Faucette, Ryan</creatorcontrib><creatorcontrib>Biedenkapp, Joseph C</creatorcontrib><creatorcontrib>Chyung, Yung H</creatorcontrib><creatorcontrib>Adelman, Burt</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis-Lorton, Mark A., MD FAAAAI</au><au>Busse, Paula J., MD FAAAAI</au><au>Banerji, Aleena, MD</au><au>Shennak, Mustafa</au><au>Lumry, William R., MD FAAAAI</au><au>Wedner, H. James, MD FAAAAI</au><au>Jacobs, Joshua S., MD</au><au>Baker, James W., MD FAAAAI</au><au>Bernstein, Jonathan A., MD</au><au>Lockey, Richard F., MD</au><au>Li, H. Henry, MD PhD</au><au>Craig, Timothy J</au><au>Cicardi, Marco</au><au>Riedl, Marc A., MD MS</au><au>Al-Ghazawi, Ahmad</au><au>Soo, Carolyn</au><au>Iarrobino, Ryan</au><au>Sexton, Daniel</au><au>TenHoor, Christopher</au><au>Faucette, Ryan</au><au>Biedenkapp, Joseph C</au><au>Chyung, Yung H</au><au>Adelman, Burt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2016-02-01</date><risdate>2016</risdate><volume>137</volume><issue>2</issue><spage>AB252</spage><epage>AB252</epage><pages>AB252-AB252</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Rationale Hereditary angioedema (HAE) attacks result from uncontrolled contact system activation which generates a burst of plasma kallikrein (pKal) that cleaves high-molecular-weight kininogen (HMWK) to produce 2-chain HMWK and the edema-inducing peptide, bradykinin.</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2015.12.908</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB252-AB252
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1765336112
source Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Allergy and Immunology
Drug dosages
Plasma
title Pharmacodynamic Effect of DX-2930 on Plasma Kallikrein in Hereditary Angioedema Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T07%3A09%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacodynamic%20Effect%20of%20DX-2930%20on%20Plasma%20Kallikrein%20in%20Hereditary%20Angioedema%20Patients&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Davis-Lorton,%20Mark%20A.,%20MD%20FAAAAI&rft.date=2016-02-01&rft.volume=137&rft.issue=2&rft.spage=AB252&rft.epage=AB252&rft.pages=AB252-AB252&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2015.12.908&rft_dat=%3Cproquest_cross%3E3953756691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1765336112&rft_id=info:pmid/&rft_els_id=1_s2_0_S0091674915026500&rfr_iscdi=true